Read the blog: #GLP1 #RealWorldData #RWE #HEOR To view or add a comment, sign in More Relevant Posts GLP1s are Booming, but building Trust and Cognition will be Challenging moving forward At JPM26, two signals around GLP-1s stood out: 1) 1.5 million patients are turning to compounded, unapproved GLP1s because approved options feel too expensive or inaccessible
Weight loss from semaglutide may change your TSH levels simply because your body's metabolic needs shift, but this reflects successful treatment, not thyroid harm
Unclear: Reassess
The powder inside that vial is delicate
Fan H, Gong N, Li TF, Ma AN, Wu XY, Wang MW, Wang YX (2015) The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating beta-endorphin release from spinal microglia